Hepatitis C virus (HCV) infection is the most commonly reported bloodborne infection in the
United States, causing substantial morbidity and mortality and costing billions of dollars …

Background: Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma (HCC).
In the United States, this form of cancer occurs in approximately 15 000 persons annually. A …

Hepatitis C virus (HCV) infection is a major source of morbidity and mortality in the United
States. HCV is transmitted primarily through parenteral exposures to infectious blood or …

Introduction: Hepatitis C is a leading cause of death from liver disease in the United States.
Acute hepatitis C infection is often asymptomatic, and> 50% of cases will progress to chronic …

The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons
with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the …

At present chronic liver disease (CLD), the third commonest cause of premature death in the
United Kingdom is detected late, when interventions are ineffective, resulting in …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Hepatitis C virus (HCV) infection is a leading cause of cirrhosis, hepatocellular carcinoma,
and liver transplantation. A better understanding of HCV disease progression and the …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

Hepatitis C virus (HCV) infects 3% of the world's population. Treatment of chronic HCV
consists of a combination of PEGylated interferon-α (PEG-IFN-α) and ribavirin (RBV). To …